At present paracetamol is widely used for symptomatic treatment in Covid-19 with poor
results. Indomethacin is a powerful anti inflammatory drug and gives relief in low doses also …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), continues to spread rapidly across China. As of 7 March 2020 …

An epidemic illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), now named Coronavirus Disease 2019 (COVID-19), occurred in Wuhan, China. 1 …

Introduction The phosphodiesterase inhibitors theophylline and pentoxifylline have anti‐
inflammatory properties that may make them useful in COVID‐19 pneumonia. We conducted …

The World Health Organization has announced COVID-19 as a pandemic in March 2020.
COVID-19 is an infectious disease caused by the severe acute respiratory syndrome …

At present, there is no vaccine or effective standard treatment for severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection (or coronavirus disease-19 (COVID-19)) …

Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …

Alarming situation has been caused due to the emergence of COVID-19 infection around the
world. There is an urgency of developing a therapeutic strategy in order to control the spread …

Objective: The objective of this study was to use LC-MS/MS to compare the
pharmacodynamic properties and bioequivalence of two 200-mg formulations of …

Since the first detection of SARS-CoV-2 in China, COVID-19 (Corona Virus Disease 2019)
has taken the lives of more than six million people. Although some antivirals seem proper for …